Diagnostics Receives an Increased CiteScore of 4.7

We are pleased to inform you that Diagnostics (ISSN: 2075-4418) has received a heightened CiteScore of 4.7.

CiteScore provides transparent metrics that enable well-informed publishing strategies, library collection development, and the benchmarking of journal performance. It is now a standard citation metric alongside SNIP and SJR that gives an up-to-date view of a journal’s impact.

The 2023 CiteScore provides an assessment of the scientific influence of journals in the 2020 to 2023 period.

This is a reflection of the excellent performance, support, and dedication of all journal editors, reviewers, authors, and readers.

Diagnostics’ CiteScore ranks as follows:

• Q2 (63 out of 167) in the “Internal Medicine” category;
• Q2 (59 out of 117) in the “Clinical Biochemistry” category. 

For more journal statistics, please visit https://www.mdpi.com/journal/diagnostics/stats.

Thank you to everyone who has contributed to the journal.

Diagnostics Editorial Office